Recursion Pharmaceuticals
Sarah Wallick, PharmD, MS, currently serves as the Director of Regulatory Affairs at Recursion, a position held since December 2024. Prior to this role, Sarah was with 23andMe from May 2021 to December 2024, where achievements included being the first regulatory hire for the Therapeutics Development organization and leading two immuno-oncology programs from preclinical through Phase 2 clinical stages. Earlier experience includes positions at Abbott as a Senior Regulatory Affairs Specialist and Senior Medical Vigilance Specialist, as well as consulting for 503B manufacturing facilities. Additional roles include serving as Regulatory Compliance Officer at California Pharmacy & Compounding Center and managing drug compounding operations at Pharmaca Integrative Pharmacy. Educational qualifications comprise a Doctorate of Pharmacy from the University of Washington and a Master’s Degree in Regulatory Affairs from Northeastern University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices